RYBREVANT + LAZCLUZE — Sales to customers (Note 9)
Products & Services · Sales to customers (Note 9)Johnson & Johnson RYBREVANT + LAZCLUZE — Sales to customers (Note 9) increased by 10.0% to $395.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 121.9%, from $178.00M to $395.00M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2024
Last reportedQ3 2025
Rolls up toTotal Revenue
How to read this metric
An increase indicates successful market penetration and strong demand for the therapeutic product line, while a decrease may signal competitive pressure or loss of market share.
Detailed definition
This metric represents the total net revenue generated from the sale of specific oncology therapeutic products to extern...
Peer comparison
Comparable to revenue figures for specific high-growth oncology or specialty pharmaceutical product lines at peer biopharmaceutical companies.
Metric ID:
jnj_segment_rybrevant_lazcluze_sales_to_customers_note_9Historical Data
6 periods
| Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|
| Value | $94.00M | $138.00M | $178.00M | $282.00M | $359.00M | $395.00M |
| QoQ Change | — | +46.8% | +29.0% | +58.4% | +27.3% | +10.0% |
| YoY Change | — | — | — | +200.0% | +160.1% | +121.9% |
Range$94.00M – $395.00M
CAGR+215.3%
Avg YoY Growth+160.7%
Median YoY Growth+160.1%
Current Streak5+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's rybrevant + lazcluze — sales to customers (note 9)?
- Johnson & Johnson (JNJ) reported rybrevant + lazcluze — sales to customers (note 9) of $395.00M in Q3 2025.
- How has Johnson & Johnson's rybrevant + lazcluze — sales to customers (note 9) changed year-over-year?
- Johnson & Johnson's rybrevant + lazcluze — sales to customers (note 9) increased by 121.9% year-over-year, from $178.00M to $395.00M.
- What does rybrevant + lazcluze — sales to customers (note 9) mean?
- The total revenue earned from selling specific oncology drugs to customers.